Ziying Chen
Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway
Chen, Ziying; Gordillo-Martinez, Flora; Jiang, Lei; He, Pengcheng; Hong, Wanzi; Wei, Xuebiao; Staines, Katherine A.; Macrae, Vicky E.e; Zhang, Chunxiang; Yu, Danqing; Fu, Xiaodong; Zhu, Dongxing
Authors
Flora Gordillo-Martinez
Lei Jiang
Pengcheng He
Wanzi Hong
Xuebiao Wei
Katherine A. Staines
Vicky E.e Macrae
Chunxiang Zhang
Danqing Yu
Xiaodong Fu
Dongxing Zhu
Abstract
Aims
Calcific aortic valve disease (CAVD) is the most common heart valve disease in the Western world. It has been reported that zinc is accumulated in calcified human aortic valves. However, whether zinc directly regulates CAVD is yet to be elucidated. The present study sought to determine the potential role of zinc in the pathogenesis of CAVD.
Methods and results
Using a combination of a human valve interstitial cell (hVIC) calcification model, human aortic valve tissues, and blood samples, we report that 20 μM zinc supplementation attenuates hVIC in vitro calcification, and that this is mediated through inhibition of apoptosis and osteogenic differentiation via the zinc-sensing receptor GPR39-dependent ERK1/2 signalling pathway. Furthermore, we report that GPR39 protein expression is dramatically reduced in calcified human aortic valves, and there is a significant reduction in zinc serum levels in patients with CAVD. Moreover, we reveal that 20 μM zinc treatment prevents the reduction of GPR39 observed in calcified hVICs. We also show that the zinc transporter ZIP13 and ZIP14 are significantly increased in hVICs in response to zinc treatment. Knockdown of ZIP13 or ZIP14 significantly inhibited hVIC in vitro calcification and osteogenic differentiation.
Conclusions
Together, these findings suggest that zinc is a novel inhibitor of CAVD, and report that zinc transporter ZIP13 and ZIP14 are important regulators of hVIC in vitro calcification and osteogenic differentiation. Zinc supplementation may offer a potential therapeutic strategy for CAVD.
Journal Article Type | Article |
---|---|
Acceptance Date | Mar 31, 2020 |
Online Publication Date | Apr 7, 2020 |
Publication Date | 2021-03 |
Deposit Date | Jun 29, 2020 |
Publicly Available Date | Apr 8, 2021 |
Journal | Cardiovascular Research |
Print ISSN | 0008-6363 |
Electronic ISSN | 1755-3245 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
Volume | 117 |
Issue | 3 |
Pages | 820-835 |
DOI | https://doi.org/10.1093/cvr/cvaa090 |
Keywords | Zinc, Valve interstitial cell calcification, Apoptosis, ERK1/2, GPR39 |
Public URL | http://researchrepository.napier.ac.uk/Output/2663675 |
Files
Zinc ameliorates human aortic valve calcification through GPR39 mediated ERK1/2 signalling pathway
(3.7 Mb)
PDF
You might also like
Models of ex vivo explant cultures: applications in bone research
(2016)
Journal Article
New developments in osteoarthritis and cartilage biology
(2016)
Journal Article
Expression of Sulf1 and Sulf2 in cartilage, bone and endochondral fracture healing
(2015)
Journal Article
Downloadable Citations
About Edinburgh Napier Research Repository
Administrator e-mail: repository@napier.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search